In addition, HDAC2 and HDAC3 were shown to facilitate the inhibition of vascular endothelial growth factor (VEGF) signaling, which promotes angiogenesis to support tumor progression, in breast cancer cells in vitro [75]. Here, VEGFA is linked to breast carcinoma.